Successful Rechallenge with Osimertinib after Very Acute Onset of Drug-Induced Pneumonitis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Successful Rechallenge with Osimertinib after Very Acute Onset of Drug-Induced Pneumonitis ; volume:14 ; number:2 ; year:2021 ; pages:733-738 ; extent:6
Case reports in oncology ; 14, Heft 2 (2021), 733-738 (gesamt 6)
- Urheber
-
Mohammed, Turab
Mangeshkar, Shaunak
Rathmann, Joerg
- DOI
-
10.1159/000516274
- URN
-
urn:nbn:de:101:1-2021090900384242093087
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mohammed, Turab
- Mangeshkar, Shaunak
- Rathmann, Joerg
Ähnliche Objekte (12)
Successful Rechallenge with Osimertinib following Osimertinib-Induced Ventricular Tachycardia: A Case Report
Hypersensitivity pneumonitis
RADIATION PNEUMONITIS
Successful osimertinib rechallenge in a patient with advanced non-small cell lung cancer following osimertinib-induced interstitial lung disease after treatment with nivolumab
Real-World Data on Subsequent Therapy for First-Line Osimertinib-Induced Pneumonitis: Safety of EGFR-TKI Rechallenge (Osi-risk Study TORG-TG2101)
Drug-induced uveitis
Hypersensitivity pneumonitis : a clinical approach
Interstitial pneumonitis following intrapleural chemotherapy
Successful cemented femoral arthroplasties reveal very often stiffened bone structures
Osimertinib and palbociclib in an EGFR-mutated NSCLC with primary CDK4 amplification after progression under osimertinib
Osimertinib tolerance in a patient with Stevens Johnson syndrome during osimertinib therapy after treatment with pembrolizumab
Drug-induced neurological disorders
Successful Rechallenge with Osimertinib following Osimertinib-Induced Ventricular Tachycardia: A Case Report
Hypersensitivity pneumonitis
RADIATION PNEUMONITIS
Successful osimertinib rechallenge in a patient with advanced non-small cell lung cancer following osimertinib-induced interstitial lung disease after treatment with nivolumab
Real-World Data on Subsequent Therapy for First-Line Osimertinib-Induced Pneumonitis: Safety of EGFR-TKI Rechallenge (Osi-risk Study TORG-TG2101)
Drug-induced uveitis
Hypersensitivity pneumonitis : a clinical approach
Interstitial pneumonitis following intrapleural chemotherapy
Successful cemented femoral arthroplasties reveal very often stiffened bone structures
Osimertinib and palbociclib in an EGFR-mutated NSCLC with primary CDK4 amplification after progression under osimertinib
Osimertinib tolerance in a patient with Stevens Johnson syndrome during osimertinib therapy after treatment with pembrolizumab
Drug-induced neurological disorders
Successful Rechallenge with Osimertinib following Osimertinib-Induced Ventricular Tachycardia: A Case Report
Hypersensitivity pneumonitis
RADIATION PNEUMONITIS
Successful osimertinib rechallenge in a patient with advanced non-small cell lung cancer following osimertinib-induced interstitial lung disease after treatment with nivolumab
Real-World Data on Subsequent Therapy for First-Line Osimertinib-Induced Pneumonitis: Safety of EGFR-TKI Rechallenge (Osi-risk Study TORG-TG2101)
Drug-induced uveitis
Hypersensitivity pneumonitis : a clinical approach
Interstitial pneumonitis following intrapleural chemotherapy
Successful cemented femoral arthroplasties reveal very often stiffened bone structures
Osimertinib and palbociclib in an EGFR-mutated NSCLC with primary CDK4 amplification after progression under osimertinib
Osimertinib tolerance in a patient with Stevens Johnson syndrome during osimertinib therapy after treatment with pembrolizumab